Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SonoSpine is a private U.S. healthcare company focused on minimally invasive ultrasonic spine surgery for back, neck, and spine disorders. The company markets the proprietary Sonosculpt procedure, which uses high-frequency ultrasonic tools to remove compressive spinal pathology with the goal of avoiding more disruptive open surgery and spinal fusion in selected patients. Rather than operating as a drug-development biotech, SonoSpine functions as a specialty surgical practice and technology-enabled care provider. Its services include MRI review, patient evaluation, and outpatient surgical treatment for conditions such as disc herniation, spinal stenosis, degenerative spine disease, and related nerve compression syndromes. The company appears to operate multiple U.S. clinic locations and is led by founder Dr. Dilantha B. Ellegala.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SonoSpine.